(Q24246249)

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

Combination Therapy for Dendritic Keratitis With Acyclovir and -Interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

Interferon in Treatment of Dendritic Keratitis in Humans: A Preliminary Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

A Controlled Trial of Adenine Arabinoside and Trifluorothymidine in Herpetic Keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

Herpes simplex keratitis in a developing country. Natural history and treatment of epithelial ulcers in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epidemiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

Newly acquired herpes simplex virus keratitis after penetrating keratoplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Herpetic Eye Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

A DOUBLE-BLIND STUDY OF IDU IN HUMAN HERPES SIMPLEX KERATITIS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

TREATMENT OF HUMAN HERPES SIMPLEX KERATITIS WITH IDOXURIDINE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Prognostic indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Combination therapy for dendritic keratitis. High-titer alpha-interferon and trifluridine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Role of débridement and trifluridine (trifluorothymidine) in herpes simplex dendritic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Aciclovir and trifluorothymidine in herpetic keratitis. Preliminary report of a multicentered trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Treatment of herpetic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Successful treatment of dendritic keratitis with human leukocyte interferon. A controlled clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Role of debridement and interferon in the treatment of dendritic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

On the treatment of dendritic keratitis with p-fluorophenylalanine. (Preliminary report)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

On the treatment of dendritic keratitis with para-fluorophenylalanine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

[Studies on the effectiveness of non-specific and virostatic treatment of dendritic keratitis with special reference to the combination of 5-iodo-2-deoxyuridine and para-fluorphenylalanine]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Acyclovir and vidarabine for the treatment of herpes simplex keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Use of acyclovir in herpetic ocular infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Acyclovir in herpes keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Multicenter trial of acyclovir and trifluorothymidine in herpetic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Double-blind clinical trial of acyclovir and adenine arabinoside in herpetic corneal ulceration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

TREATMENT OF HERPES SIMPLEX OF THE CORNEA WITH IDU. A DOUBLE-BLIND STUDY

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Clinical Evaluation of Trifluorothymidine in the Treatment of Herpes Simplex Corneal Ulcers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Clinical Evaluation of Adenine Arabinoside and Idoxuridine in the Treatment of Ocular Herpes Simplex

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Proflavine Photodynamic Viral Inactivation in Herpes Simplex Keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Therapy selection in an expert medical consultation system for ocular herpes simplex

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Levamisole therapy: clinical and immunological evaluation in herpetic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Comparative study of ocular herpes simplex virus in patients with and without self-reported atopy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Incidence of herpes simplex virus keratitis in France

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Herpetic eye disease in diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Acyclovir and vidarabine in the treatment of ulcerative herpes simplex keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Combination Therapy for Dendritic Keratitis with Human Leukocyte Interferon and Acyclovir

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Treatment of herpes keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Topical therapy of ulcerative herpetic keratitis with human interferon

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Letter: Interferon treatment of dendritic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Combination therapy of dendritic keratitis with trifluorothymidine and interferon

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

A double-blind, multicenter clinical trial of acyclovir vs idoxuridine for treatment of epithelial herpes simplex keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Combination therapy of recombinant human alpha 2 interferon and acyclovir in the treatment of herpes simplex keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Recall bias in a prospective cohort study of acute time-varying exposures: example from the herpetic eye disease study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Berofor alpha 2 (r-HUIFN-alpha 2 arg) and acyclovir in the treatment of dendritic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Clinical experience with different methods of treating herpes corneae (author's transl)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Combination therapy for dendritic keratitis with acyclovir and vidarabine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

The evolution of antiviral therapy for external ocular viral infections over twenty-five years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Clinical experience with nucleosides in herpes simplex eye infections in man and animals

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Clinical application of adenine arabinoside

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

TREATMENT OF DENDRITIC KERATITIS WITH INTERFERON

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Dendritic (herpetic) keratitis. I. Incidence--seasonal variations--recurrence rate--visual impairment--therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Oxyphenbutazonum (Tanderil) as an adjuvant in treatment of dendritic keratitis. Double-blind trial using fluorescein-rose bengal vital staining

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Keratitis dendritica. An epidemiological investigation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Acyclovir in the treatment of herpetic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Acyclovir and idoxiuridine treatment of herpes simplex keratitis--a double blind clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

A comparison between acyclovir and trifluorothymidine ophthalmic ointment in the treatment of epithelial dendritic keratitis. A double blind, randomized parallel group trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Phosphonoformate (foscarnet, PFA) versus trifluorthymidine in the treatment of keratitis dendritica in the human. A double-blind, randomized, preliminary trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

TREATMENT OF HERPES SIMPLEX KERATITIS WITH 5-IODO-2'-DEOXYURIDINE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

IDU AND THE TREATMENT OF HERPES SIMPLEX KERATITIS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

A COMPARISON OF IDU SOLUTION, IDU OINTMENT, AND CARBOLIZATION IN THE TREATMENT OF DENDRITIC CORNEAL ULCER

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Management of ocular herpes simplex

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Assessment of possible potentiating action of ultraviolet light on 5 iodo-2' deoxyuridine in superficial herpetic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Treatment of amoeboid herpetic ulcers with adenine arabinoside or trifluorothymidine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Trifluorothymidine versus adenine arabinoside in the treatment of herpes simplex keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

A randomised double-blind clinical trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex corneal ulceration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Acyclovir and trifluorothymidine in herpetic keratitis: a multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Combination therapy for dendritic keratitis with human leucocyte interferon and trifluorothymidine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Oral acyclovir in the management of dendritic herpetic corneal ulceration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

[HERPES SIMPLEX KERATITIS. 1 YEAR EXPERIENCE WITH IDOXURIDINE]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

The incidence of herpetic keratitis among population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Interferon-beta treatment of herpes simplex keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Epidermal growth factor in the topical treatment of herpetic corneal ulcers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Vidarabine: a preliminary review of its pharmacological properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Acyclovir A Review of its Pharmacodynamic Properties and Therapeutic Efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Herpetic keratitis therapy to reduce recurrence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Blunt spatula debridement and trifluorothymidine in epithelial herpetic keratitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

The potency of interferon-alpha 2 and interferon-gamma in a combination therapy of dendritic keratitis. A controlled clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration: a double blind controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Development of antiviral therapy with alpha interferons: promises, false hopes and accomplishments

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021

Further studies on clinical trials of interferon in Japan

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002898.PUB2

7 January 2021